Monitor for any subsequent prospectus supplement or 424B filing that would indicate an actual offering. The effective shelf creates overhang that may pressure the stock, especially given the weak analyst sentiment and small market cap. Any takedown could be significantly dilutive relative to current market cap.
Price Chart
Executive Summary
NewcelX Ltd.'s F-3 shelf registration (File No. 333-295770) became effective on May 15, 2026, allowing the company to offer and sell securities from time to time. This creates potential dilution overhang for the $17M market cap pharmaceutical company, though no specific offering has been announced.
Key Facts
- F-3 shelf registration became effective on May 15, 2026
- Company has a $17M market cap and operates in pharmaceutical preparations
- No specific offering size or terms disclosed in the filing
- Formerly known as NLS Pharmaceutics Ltd. (name change July 2019)
- Analyst consensus is 0% bullish with 3 Hold, 1 Sell, 2 Strong Sell ratings
Financial Impact
Potential dilution from future shelf takedowns; no specific offering amount disclosed
Risk Factors
- Future equity offering could be highly dilutive given $17M market cap
- Weak analyst consensus (0% bullish) suggests limited institutional support
- No disclosed use of proceeds or specific offering plan
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-001675 |
| Document: 9999999995-26-001675-index.html | 9999999995-26-001675 |
| Document: 9999999995-26-001675.txt | 9999999995-26-001675 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 23, 2026 4w ago | EFFECT | $2.86 $3.08 | ▼ −7.52% | ▼ −8.19% | $2.55 (+10.84%) |
Sep 18, 2026 5w ago | 6-K | $2.97 $2.92 | ▲ +1.68% | ▲ +0.66% | $2.55 (+14.14%) |
Aug 27, 2026 8w ago | EFFECT | $3.42 $3.35 | ▲ +2.05% | ▲ +1.28% | $2.55 (+25.44%) |
Jul 31, 2026 12w ago | 6-K | $3.49 $3.31 | ▼ −5.16% | ▼ −8.67% | $2.55 (−26.93%) |
Jul 15, 2026 14w ago | 6-K | $3.93 $3.65 | ▼ −7.12% | ▼ −6.14% | $2.55 (−35.11%) |
Jul 8, 2026 15w ago | 6-K | $4.23 $3.98 | ▼ −5.91% | ▼ −6.77% | $2.55 (−39.72%) |
Jul 1, 2026 16w ago | 6-K | $3.85 $4.01 | ▲ +4.16% | ▲ +3.89% | $2.55 (−33.77%) |
Jun 30, 2026 16w ago | 6-K | $3.85 $4.01 | ▲ +4.16% | ▲ +3.89% | $2.55 (−33.77%) |
Jun 18, 2026 18w ago | EFFECT | $3.31 $3.55 | ▼ −7.25% | ▼ −8.92% | $2.55 (+22.96%) |
Jun 5, 2026 20w ago | 6-K | $3.24 $3.20 | ▼ −1.23% | ▼ −3.35% | $2.55 (−21.30%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers